The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Professor of Medicine, Department of Digestive Diseases, Hepatology and Liver Transplantation Unit, La Fe University Hospital and CIBERehd, Valencia, Spain
Professor Marina Berenguer is a Consultant Hepatologist at La Fe University Hospital in Valencia, Spain, where she is responsible for the Hepatology and Liver transplantation Unit. She trained in medicine at the University of Valencia before completing a fellowship at the VA Medical Center / University of California (USA) with Dr. T. Wright. She is also Full Professor of Medicine at the University of Valencia, Faculty of Medicine.
President of the International Liver Transplant Society in 2021-2022.
Research Coordinator within a National Network Research Center in Hepatology, CIBER-EHD, leading one of the few CIBER groups in the Valencia region and Coordinator of La Fe University Research Group “Hepatology, Hepatobiliopancreatic surgery and Transplantation”.
Prof. Berenguer is recognised internationally in the field of Hepatology with extensive research covering clinical, basic, and translational works. Regular invited speaker in Hepatology forums, including the direction of Postgraduate & Transplant Courses and Consensus Conferences from which clinical practice guidelines endorsed by the American, European, International or Spanish Liver or Transplant Societies are issued (Hepatitis C: 2013, 2016, 2018, 2020 -AASLD, EASL, ILTS, AEEH; Alcoholic liver disease: ILTS 2017; Immunosuppression: ILTS 2018; metabolically-associated liver disease: ILTS 2018, extrahepatic cancer and LT: ILTS 2021; ERAS in LT: ILTS 2022; ACLF: EASL 2023; Biomarkers in Liver Transplantation: ESOT 2023).
COUNCILLOR in different Societies, such as the European Organ Transplant (2011-14), the European LT (ELITA: 2017-19), ILTS (2013-17; 2019-2023), Spanish Liver (AEEH-2009-10, 2013-14), Digestive (SEPD, 2004-08) or Transplantation (SET, 2019-2023) Societies.
ASSOCIATE EDITOR in “Liver Transpl” and “J. Hepatol” from 2010 to 2014 and DEPUTY Editor in “Transplantation” (2015-19) and J Hep Report (2019-2023).
Consultant/expert in National Grant Committees, such as the “Agence Nationale de la Recherche” (France) and the “Instituto de Salud Carlos III” (Spain).
Co-founder in 2016 of the Spanish Group of Women Hepatologists (GEMHEP) as well as first chair of the Women (EDI) Committee within ILTS.
Recipient of several Awards, including the Medical-Scientific Award from the Liver Transplant Patient Association (2007), the Mayo Clinic award (2014), the Professionalism Award granted by EVAP- Business and Professional Association (2019) and the award “Una de Primera” by the Federation of First Class Fallas as recognition for women of great influence in the Valencian Community not directly related to the world of fallas in 2023. In addition, she received the Professional Trajectory Recognition by the Valencian Government in 2010. In 2023, she has been nominated to join the Royal Academy of Medicine of the Valencian Community.
